Lonza | LONN - Assets



Lonza reported CHF19.73B in Assets for its fiscal semester ending in December of 2024.


Assets Change Date
Akzo Nobel EUR 14.17B 680M Jun/2025
Alcon AG USD 31.39B 379M Jun/2025
Almirall EUR 2.31B 88.18M Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
BASF EUR 77.67B 3.75B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Beiersdorf EUR 12.92B 87M Jun/2025
Covestro EUR 13.21B 844M Jun/2025
Demant DKK 32.64B 190M Jun/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Fresenius Medical Care EUR 31.29B 1.44B Jun/2025
Geberit CHF 3.83B 192.6M Mar/2025
Genmab DKK 6.46B 122M Jun/2025
Givaudan CHF 12.18B 1.05B Jun/2024
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
GN Store Nord DKK 29.49B 451M Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Johnson Matthey GBP 6.19B 59M Mar/2025
Merck EUR 47.35B 2.02B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Philips EUR 26.38B 788M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
Sika AG CHF 15.98B 157.2M Dec/2024
Smith & Nephew USD 10.69B 338M Jun/2025
Solvay EUR 6.3B 48M Jun/2025
UCB EUR 17.35B 1.72B Dec/2024